Loading…
Nephros, Inc. is projected to rise to $4.93 by 2027, a +41% move from its current price of $3.63. NEPH is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $3.50 | $3.63 | $3.77 | +0.08% |
| Jul 14 | $3.46 | $3.64 | $3.83 | +0.17% |
| Jul 15 | $3.42 | $3.64 | $3.87 | +0.25% |
| Jul 16 | $3.39 | $3.64 | $3.91 | +0.33% |
| Jul 17 | $3.36 | $3.64 | $3.95 | +0.41% |
| Jul 18 | $3.34 | $3.65 | $3.99 | +0.50% |
| Jul 19 | $3.32 | $3.65 | $4.02 | +0.58% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.32 | $3.65 | $4.02 | +0.58% |
| Week 2 | $3.21 | $3.67 | $4.20 | +1.16% |
| Week 3 | $3.13 | $3.69 | $4.36 | +1.75% |
| Week 4 | $3.07 | $3.71 | $4.50 | +2.34% |
| Week 5 | $3.02 | $3.74 | $4.63 | +2.93% |
| Week 6 | $2.97 | $3.76 | $4.75 | +3.52% |
| Week 7 | $2.94 | $3.78 | $4.87 | +4.12% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Nephros, Inc. is a commercial-stage company that develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities.
The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants.
The company was incorporated in 1997 and is headquartered in South Orange, New Jersey. It is categorized in Healthcare.
Nephros, Inc. trades under the symbol NEPH and operates in the Healthcare sector as a water filtration solutions provider for medical and commercial applications in the United States.
Its current price is $3.31, and its market capitalization is $35.94M, with a rank of 4697.
A major floor 23.4% below — a decisive break under it would weaken the trend.
The nearest floor, 13.8% below — buyers have tended to step in here.
The nearest ceiling, 4.7% above — a clean break opens room to run.
A major ceiling 15.4% above — clearing it would confirm fresh momentum.
Key NEPH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NEPH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.48 | Buy | $3.50 | Buy |
| MA 10 | $3.49 | Buy | $3.46 | Buy |
| MA 20 | $3.37 | Buy | $3.43 | Buy |
| MA 50 | $3.39 | Buy | $3.40 | Buy |
| MA 100 | $3.36 | Buy | $3.52 | Buy |
| MA 200 | $4.11 | Sell | $3.63 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 57.21 | Neutral |
| Stoch RSI (14) | 87.35 | Sell |
| CCI (20) | 135.17 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 10.00 | Buy |
| Bollinger %B (20,2) | 0.92 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.06 | Buy |
| Awesome (5,34) | 0.04 | Buy |
| Ultimate (7,14,28) | 56.03 | Neutral |
| Momentum (10) | 0.36 | Buy |
| Aroon Osc (25) | -32.00 | Sell |
| Hull MA (9) | 3.46 | Buy |
| ADX (14) | 9.06 | Neutral |
| ATR (14) | 0.11 | Info |
The near-term technical picture is neutral. The RSI14 is 50, indicating a balanced momentu m with no overbought or oversold signals.
The stock’s moving averages show SMA50 at $3.38 and SMA200 at $4.12, providing a short-term framework for supports and resistances.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.78 | $3.50 | $5.22 | 0% | Neutral | |
| $3.81 | $4.93 | $6.82 | +41% | Bullish | |
| $4.38 | $5.90 | $8.55 | +69% | Bullish | |
| $4.79 | $6.65 | $10.00 | +90% | Bullish | |
| $4.17 | $5.96 | $9.23 | +70% | Bullish | |
| $4.41 | $6.47 | $10.28 | +85% | Bullish | |
| $5.18 | $7.79 | $12.69 | +123% | Bullish | |
| $5.85 | $8.99 | $14.96 | +157% | Bullish | |
| $6.89 | $10.83 | $18.37 | +209% | Bullish | |
| $6.86 | $11.02 | $19.03 | +215% | Bullish | |
| $10.09 | $17.90 | $33.28 | +411% | Bullish | |
| $13.01 | $27.58 | $57.08 | +688% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.78 | $3.50 | $4.41 | -3.58% |
| August 2026 | $3.30 | $3.93 | $4.83 | +12.29% |
| September 2026 | $3.26 | $3.91 | $4.88 | -0.43% |
| October 2026 | $3.18 | $3.86 | $4.87 | -1.42% |
| November 2026 | $3.28 | $4.01 | $5.11 | +3.83% |
| December 2026 | $3.30 | $4.05 | $5.22 | +1.19% |
Click any year to see its month-by-month NEPH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect NEPH to range from $2.78 to $5.22 through 2026. The $3.50 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The NEPH price prediction for 2027 points to an average of $4.93 (low $3.81, high $6.82) — a potential gain of +41% on today's $3.63. Buyers look set to stay in control over this stretch.
In 2028, NEPH is projected to trade between $4.38 and $8.55, averaging $5.90 — a potential gain of +69% from today's $3.63. That is up +20% on the projected 2027 average. Momentum favours further upside here.
Nephros, Inc.'s 2029 outlook centres on $6.65, within a $4.79 to $10.00 range. That is up +13% on the projected 2028 average. That marks a +90% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, NEPH could reach as high as $9.23, with a base case around $5.96 and support toward $4.17 — roughly +70% from $3.63. Momentum favours further upside here.
Expect NEPH to range from $4.41 to $10.28 through 2031. The $6.47 average target implies a +85% move from current prices. That is up +9% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The NEPH price prediction for 2032 points to an average of $7.79 (low $5.18, high $12.69) — a potential gain of +123% on today's $3.63. Momentum favours further upside here.
In 2033, NEPH is projected to trade between $5.85 and $14.96, averaging $8.99 — a potential gain of +157% from today's $3.63. That is up +15% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Nephros, Inc.'s 2034 outlook centres on $10.83, within a $6.89 to $18.37 range. That is up +20% on the projected 2033 average. That marks a +209% change versus current levels. Momentum favours further upside here.
By 2035, NEPH could reach as high as $19.03, with a base case around $11.02 and support toward $6.86 — roughly +215% from $3.63. Buyers look set to stay in control over this stretch.
Expect NEPH to range from $10.09 to $33.28 through 2040. The $17.90 average target implies a +411% move from current prices. That is up +62% on the projected 2035 average. Momentum favours further upside here.
The NEPH price prediction for 2050 points to an average of $27.58 (low $13.01, high $57.08) — a potential gain of +688% on today's $3.63. Buyers look set to stay in control over this stretch.
Investing $1,000 in NEPH today (≈ 275.482094 NEPH) could be worth
$7,596.79
+$6,596.79 (+660%) by 2050 · US Dollar
Based on the average projected NEPH price of $27.58 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NEPHwould be worth at today's price.
$1,000 invested in NEPH on Jul 10, 2025 (≈ 266.666667 NEPH) would be worth
$968
-$32 (-3.2%) today · 0.97× · US Dollar
Based on a NEPH entry price of $3.75 vs. today's $3.63.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.4 | $1,067.65 | +6.8% |
| 1 month ago | $3.2 | $1,134.37 | +13.4% |
| 3 months ago | $2.96 | $1,226.35 | +22.6% |
| 6 months ago | $4.54 | $799.56 | -20.0% |
| 1 year ago | $3.75 | $968 | -3.2% |
| All time (5.0y) ago | $9.45 | $384.13 | -61.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NEPH forecast.
Our base-case forecast reaches $7.30 around 2032.
Implied market cap at $7.30: $79.25M
The multi-year forecast shows bullish sentiment from 2027 onward, with 2026 listed as neutral. The avg forecast for 2027 is $4.53, for 2028 is $5.41, for 2029 is $6.02, for 2030 is $5.35, for 2031 is $5.77, for 2032 is $6.79, for 2033 is $7.75, for 2034 is $9.38, for 2035 is $9.50, for 2040 is $15.06, and for 2050 is $22.55. The max forecasts rise to $46.48 by 2050, with the 2030 max at $8.27 and the 2040 max at $27.90.
ROI figures accompany the years, with 2026 at 0, 2027 at 36.9, 2028 at 63.5, 2029 at 81.8, 2030 at 61.7, 2031 at 74.2, 2032 at 105.3, 2033 at 134.1, 2034 at 183.3, 2035 at 187, 2040 at 354.9, and 2050 at 581.4. These estimates imply a rising price profile and a progressively stronger upside potential over time, though they are not guarantees and carry uncertainty.
Overall, the longer-term outlook suggests meaningful upside from the current level, with the avg price moving toward the mid-to-upper teens by 2040 and into the low-to-mid twenties by 2050, accompanied by substantial ROI potential.
Tap a question to reveal the answer.
Avg $5.35; min $3.75; max $8.27; ROI 61.7; sentiment BULLISH.
The forecast shows a progression to bullish sentiment from 2027 onward with rising average prices and ROI figures, including 2030 Avg $5.35 and 2050 Avg $22.55, but these are estimates and not guarantees.
Yes, based on the forecast, the max for 2034 is $15.85 and 2035 max is $16.35, indicating potential to exceed $10 in the forecast horizon.
Current price is $3.31 and market cap is $35.94M.
The 30-day view is neutral with RSI 50. Support is $3.13 and resistance is $3.80; the 30-day range is $2.62 to $4.19 and volatility is 70%.
Nephros, Inc. Community Discussion
0Share your Nephros, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.